Showing results (181-190 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|November 22, 2023
Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillationMette Søgaard, Anne Gulbech Ording, Flemming Skjøth, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2023
Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort studyNam Hoon Kim, Ji Yoon Kim, Jimi Choi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2023
Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysisMattia Galli, Renzo Laborante, Giovanni Occhipinti, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2023
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort studyXinyi Gao, Nan Zhang, Lei Lu, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 18, 2024
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trialRaffaele Piccolo, Fiorenzo Simonetti, Marisa Avvedimento, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisBruna Gigante, Juan Tamargo, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysisMattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 5, 2023
Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort studyMia Ravn Jacobsen, Reza Jabbari, Thomas Engstrøm, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 5, 2019
Adherence to dabigatran etexilate in atrial fibrillation patients intended to undergo electrical cardioversionWillemijn J Comuth, Moniek P M de Maat, Daan van de Kerkhof, et al.
Pageof 53